Caplight Directory>Companies>BreezeBio-preview>Breezebio


BreezeBio

BreezeBio

Private
Brisbane, CaliforniaHealthcare & Life Scienceshttps://breezebio.com/

Last Round

Series B

Feb 25, 2026

Total Funding Raised

$60M

Company Overview

BreezeBio is a biotechnology company developing genetic medicines enabled by precise, non-viral delivery across biologically relevant tissues using its proprietary NanoGalaxy® platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

genetic medicinesnon-viral deliverydrug delivery platformnanoparticlesmRNA deliverygene therapygene editingautoimmune disease therapyCRISPR deliverynanomedicineoncology therapeuticsbiopharma partnershipstype 1 diabetes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BreezeBio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BreezeBio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 25, 2026
View all Funding Rounds

BreezeBio Investors

Notable investors and investment history

InvestorRounds
SV InvestmentSeries B
DSC InvestmentSeries B
DAYLI PartnersSeries B
Korea Investment PartnersSeries B
Pathway Capital ManagementSeries B
Top Harvest CapitalSeries B
KDB Silicon ValleySeries B
View all Investors

BreezeBio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BreezeBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BreezeBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrisbane, California
Year Founded2016
Last FundingFeb 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.